Analysis of polymorphisms in the interleukin 18 gene promotor (-137 G/C and -607 C/A) in patients infected with hepatitis C virus from the Brazilian Amazon;Análise do polimorfismo na região promotora do gene da interleucina 18 (-137 G/C e -607 C/A) em pacientes portadores do vírus da hepatite C na Amazônia Brasileira

Arquivos de Gastroenterologia

Volumn 52, Issue 3, 2015, Pages 222-227

  dos Santos, Kemper Nunes ^a   de Almeida, Marcella Kelly Costa ^a   Fecury, Amanda Alves ^a   da Costa, Carlos Araújo ^a   Martins, Luísa Caricio ^a  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

Author keywords

Hepacivirus; Hepatitis C; Interleukin 18; Single nucleotide polymorphism

Indexed keywords

INTERLEUKIN 18; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; EVALUATION AND FOLLOW UP; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPING TECHNIQUE; HEPATITIS C; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIOECONOMICS; BRAZIL; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; POLYMERASE CHAIN REACTION; PROMOTER REGION;

BRAZIL; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS C; HUMANS; INTERLEUKIN-18; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RNA, VIRAL;

EID: 84945183060     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032015000300013     Document Type: Article

References (23)

1. An P, Thio CL, Kirk GD, Donfield S, Goedert JJ, Winkler CA. Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance. J Infect Dis. 2008;198(8):1159-65.
2. Arimitsu J, Hirano T, Higa S, Kawai M, Naka T, Ogata A, et al. IL-18 gene poly­morphisms affect IL-18 production capability by monocytes. Biochem Biophys Res Commun. 2006;342(4):1413–6.
3. Asselah T, Estrabaud E, Bieche I, Lapalus M, De Muynck S, Vidaud M, et al. Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin. Liver Int. 2010;30(9):1259-69.
4. Ayres M, Ayres Junior M, Ayres DM, Dos Santos AS. Bio Estat 5.0: aplicações estatísticas das ciências biológicas e médicas, 5. ed. Belém: Sociedade Civil Ma­mirauá. MCTCNPq, 2007.
5. Baldick CJ, Wichroski MJ, Pendri A, Walsh AW, Fang J, Mazzucco CE, et al. A novel small lmolecule inibhitor of hepatitis C vírus entry. PLoS Pathog. 2010;6(9):e1001086.
6. Bouzgarrou N, Hassen E, Schvoerer E, Stool-Keller F, Bahri O, Gabbouj S, et al. Association of Interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection. J Med Virol. 2008;80(40):607-14.
7. Campiotto S, Pinho JRR, Carrilho FJ, Da Silva LC, Souto FJD, Spinelli V, et al. Geographic distribution of hepatitis C vírus genotypes in Brazil. Braz J Med Biol Res. 2005;38(1):41-9.
8. Castello G, Scala S, Palmieri G, Curley SA, Izzo F. HCV-related hepatocellular carcinoma: from chronic inflammation to cancer. Clin Immunol. 2010;134(3):237-50.
9. Giedraitis V, He B, Huang W-X, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol. 2001;112(1-2):146-52.
10. Haas SL, Weiss C, Bugert P, Gundt J, Witt H, Singer MV, et al. Interleukin 18 promoter variants (-137G>C and -607C>A) in patients with chronic hepatitis C: association with treatment response. J Clin Immunol. 2009;29(5):620-8.
11. Hazari S, Acharya SK, Panda SK. Development and evaluation of a quantita­tive competitive reverse transcription polymerase chain reaction (RT-PCR) for hepatitis C virus RNA in serum using transcribed thio-RNA as internal control. J Virol Methods. 2004;116(1):45-54.
12. Manohar K, Suneetha PV, Sukriti Pati NT, Gupta AC, Hissar S, Sakhuja P, Sarin SK. Associationof IL-18 promoter polymorphism with liver disease severity in HCV-infected patients. Hepatology International. 2009;3(2):371-7.
13. Mihm S, Fayyazi A, Hartmann H, Ramadori G. Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology. 1997;25(3):735-9.
14. Morales RJP, Rodriguez TRV, Torres O, Morado IC, Castañeda S, Filloy JAM, et al. Association between IL-18 gene polymorphisms and biopsy-proven giant cell arteritis. Arthritis Res Ther. 2010;12(2):1-7.
15. Nousbaum J-B, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med. 1995;122(3):161-8.
16. Oliveira CSF, Silva AV, Santos KN, Fecury AA, Almeida MKC, Fernades AP, et al. Hepatitis B and C virus infection among Brazilian Amazon riparians. Rev Soc Bras Med Trop. 2011;44(5):546-50.
17. Puoti C, Guarisco R, Bellis L, Spilabotti L. Diagnosis, management, and treatment of hepatitis C. Hepatology. 2009;50(1):322.
18. Sawada L, Pinheiro AC, Locks D, Pimenta A do S, Rezende PR, et al. Distribution of hepatitis C virus genotypes among different exposure categories in the State of Pará, Brazilian Amazon. Rev Soc Med Trop. 2011;44(1):8-12.
19. Shin HD, Kim LH, Park BL, Choi YH, Park HS, Hong SJ, et al. Association of interleukin 18 (IL18) polymorphisms with specific IgE levels to mite allergens among asthmatic patients. Allergy. 2005;60(7):900–6.
20. Singh S, Gupta R, Malhotra V, Sarin SK. Predictors of histological activity and fibrosis in chronic hepatitis C infection: a study from North India. Ind J Pathol Microbiol. 2010;53(2):238-43.
21. Tomanovic NR, Boricic IV, Brasanac DC, Stojsic ZM, Delic DS, Brmbolic BJ. Activated liver stellate cells in chronic viral C hepatitis: histopathological and immunohistochemical study. Journal Gastrointestinal Liver Diseases. 2009;18(2):163-7.
22. Viso ATR, Barbosa TC, Yamamoto L, Pagliari C, Fernandes ER, Brasil RA, Andrade Junior HF, Duarte MIS, Barone AA. Portal CD4+ and CD8+ T lym­phocyte correlate to intensity of interface hepatitis in chronic hepatitis C. Rev Inst Med trop S Paulo, 2007;49(6):371-8.
23. Yue M, Wang J, Tang S, Feng L, Zhang Y, Liu Y, et al. Association of interleu­kin-18 gene polymorphisms with the outcomes of hepatitis C virus infection in high-risk Chinese Han population. Immunol Lett. 2013;154(1-2):54-60.